YTE reported $16.37B in Market Capitalization this March of 2023, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Acadia Pharmaceuticals ACAD:US USD 2.58B 70M
Agenus AGEN:US USD 732M 151M
Agios Pharmaceuticals AGIO:US USD 1.54B 7M
Alnylam Pharmaceuticals ALNY:US USD 29.24B 4.62B
Amgen AMGN:US USD 140.14B 19.78B
Biocryst Pharmaceuticals BCRX:US USD 2.14B 203M
Biogen BIIB:US USD 39.88B 774M
Biomarin Pharmaceutical BMRN:US USD 19.23B 3.51B
Bluebird Bio BLUE:US USD 488M 192M
Bristol Myers Squibb BMY:US USD 152.98B 1.18B
Clovis Oncology CLVS:US USD 172M 87M
Cti Biopharma CTIC:US USD 763M 97M
Eli Lilly And LLY:US USD 347.61B 40.37B
Exelixis EXEL:US USD 5.17B 128M
Gilead Sciences GILD:US USD 107.68B 30.32B
Idera Pharmaceuticals IDRA:US USD 23M 1000K
Intercept Pharmaceuticals ICPT:US USD 512M 62M
Macrogenics MGNX:US USD 413M 200M
Merk MRK:US USD 281.3B 63.14B
Mirati Therapeutics MRTX:US USD 2.61B 1.28B
Moderna Inc MRNA:US USD 69.01B 22.75B
Nektar Therapeutics NKTR:US USD 425M 175M
Neurocrine Biosciences NBIX:US USD 11.48B 1.32B
Newlink Genetics NLNK:US USD 30M 44M
Novartis NOVN:VX USD 200.93B 19.37B
Novartis NVS:US USD 217.36B 33.38B
Pfizer PFE:US USD 287.63B 42.03B
Ptc Therapeutics PTCT:US USD 2.74B 863M
Puma Biotechnology PBYI:US USD 194M 86M
Regeneron Pharmaceuticals REGN:US USD 78.57B 3.48B
Sarepta Therapeutics SRPT:US USD 11.38B 1.7B
Seattle Genetics SGEN:US USD 23.86B 1.38B
Ultragenyx Pharmaceutical RARE:US USD 3.25B 348M
Vertex Pharmaceuticals VRTX:US USD 74.13B 169M
YTE INCY:US USD 17.87B 3.05B